Malat1 as an evolutionarily conserved lncRNA, plays a positive role in regulating proliferation and maintaining undifferentiated status of early-stage hematopoietic cells

BMC Genomics

Volumn 16, Issue 1, 2015, Pages

  Ma, Xian Yong ^a   Wang, Jian Hui ^a   Wang, Jing Lan ^a   Ma, Charles X ^b   Wang, Xiao Chun ^c   Liu, Feng Song ^c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^c HEBEI UNIVERSITY   (China)

Author keywords

ATRA; EML; Hematopoiesis; lncRNA; Malat1; p53

Indexed keywords

ANIMAL CELL; ARTICLE; BINDING SITE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENETIC CONSERVATION; HEMATOPOIETIC STEM CELL; MALAT1 GENE; MOUSE; NONHUMAN; PROMOTER REGION; REGULATORY MECHANISM; RNA GENE; SEQUENCE ANALYSIS; TISSUE DISTRIBUTION; TUMOR SUPPRESSOR GENE; ANIMAL; BAGG ALBINO MOUSE; BONE MARROW; CONSERVED SEQUENCE; DRUG EFFECTS; GENETIC TRANSCRIPTION; GENETICS; HEMATOPOIESIS; HUMAN; LIVER; LYMPHOCYTE; METABOLISM; MOLECULAR EVOLUTION; PRIMATE; SPECIES DIFFERENCE; UPREGULATION;

LONG UNTRANSLATED RNA; MALAT1 LONG NON-CODING RNA, HUMAN; MALAT1 LONG NON-CODING RNA, MOUSE; PROTEIN BINDING; PROTEIN P53; RETINOIC ACID;

ANIMALS; BONE MARROW; CELL DIFFERENTIATION; CELL PROLIFERATION; CONSERVED SEQUENCE; DOWN-REGULATION; EVOLUTION, MOLECULAR; HEMATOPOIESIS; HUMANS; LIVER; LYMPHOCYTES; MICE, INBRED BALB C; PRIMATES; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RNA, LONG NONCODING; SPECIES SPECIFICITY; TRANSCRIPTION, GENETIC; TRETINOIN; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 84940666605     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/s12864-015-1881-x     Document Type: Article

References (40)

1. Ji P, Diederichs S, Wang W, Boing S, Metzger R, Schneider PM, et al. MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene. 2003;22(39):8031-41.
2. Yamada K, Kano J, Tsunoda H, Yoshikawa H, Okubo C, Ishiyama T, et al. Phenotypic characterization of endometrial stromal sarcoma of the uterus. Cancer Sci. 2006;97(2):106-12.
3. Guffanti A, Iacono M, Pelucchi P, Kim N, Solda G, Croft LJ, et al. A transcriptional sketch of a primary human breast cancer by 454 deep sequencing. BMC Genomics. 2009;10:163.
4. Guo F, Li Y, Liu Y, Wang J, Li Y, Li G. Inhibition of metastasis-associated lung adenocarcinoma transcript 1 in CaSki human cervical cancer cells suppresses cell proliferation and invasion. Acta Biochim Biophys Sin. 2010;42(3):224-9.
5. Xu C, Yang M, Tian J, Wang X, Li Z. MALAT-1: a long non-coding RNA and its important 3' end functional motif in colorectal cancer metastasis. Int J Oncol. 2011;39(1):169-75.
6. Luo JH, Ren B, Keryanov S, Tseng GC, Rao UN, Monga SP, et al. Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas. Hepatology. 2006;44(4):1012-24.
7. Qi P, Du X. The long non-coding RNAs, a new cancer diagnostic and therapeutic gold mine. Modern Pathology: Off J United States Canadian Acad Pathology Inc. 2013;26(2):155-65.
8. Koshimizu TA, Fujiwara Y, Sakai N, Shibata K, Tsuchiya H. Oxytocin stimulates expression of a noncoding RNA tumor marker in a human neuroblastoma cell line. Life Sci. 2010;86(11-12):455-60.
9. Lipovich L, Johnson R, Lin CY. MacroRNA underdogs in a microRNA world: evolutionary, regulatory, and biomedical significance of mammalian long nonprotein-coding RNA. Biochimicaetbiophysicaacta. 2010;1799(9):597-615.
10. Liu JH, Chen G, Dang YW, Li CJ, Luo DZ. Expression and prognostic significance of lncRNA MALAT1 in pancreatic cancer tissues. APJCP. 2014;15(7):2971-7.
11. Ren S, Liu Y, Xu W, Sun Y, Lu J, Wang F, et al. Long noncoding RNA MALAT-1 is a new potential therapeutic target for castration resistant prostate cancer. J Urol. 2013;190(6):2278-87.
12. Zhang Q, Su M, Lu G, Wang J. The complexity of bladder cancer: long noncoding RNAs are on the stage. Mol Cancer. 2013;12(1):101.
13. Wang J, Su L, Chen X, Li P, Cai Q, Yu B, et al. MALAT1 promotes cell proliferation in gastric cancer by recruiting SF2/ASF. Biomed Pharmacother. 2014;68((5):557-64.
14. Gutschner T, Hämmerle M, Eissmann M, Hsu J, Kim Y, Hung G, et al. The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res. 2013;73(3):1180-9.
15. Watts R, Johnsen VL, Shearer J, Hittel DS. Myostatin-induced inhibition of the long noncoding RNA Malat1 is associated with decreased myogenesis. Am J Physiol Cell Physiol. 2013;304(10):C995-C1001.
16. Lin M, Pedrosa E, Shah A, Hrabovsky A, Maqbool S, Zheng D, et al. RNA-Seq of human neurons derived from iPS cells reveals candidate long non-coding RNAs involved in neurogenesis and neuropsychiatric disorders. PLoS One. 2011;6(9), e23356.
17. Kryger R, Fan L, Wilce PA, Jaquet V. MALAT-1, a non protein-coding RNA is upregulated in the cerebellum, hippocampus and brain stem of human alcoholics. Alcohol. 2012;46(7):629-34.
18. Le-Niculescu H, Balaraman Y, Patel S, Tan J, Sidhu K, Jerome RE, et al. Towards understanding the schizophrenia code: an expanded convergent functional genomics approach. Am J Med Genet B Neuropsychiatr Genet. 2007;144B(2):129-58.
19. David LS, Angus IL. Nuclear Speckes. Cold Spring Harb Perspect Biol. 2011;3(2):a000646.
20. Tripathi V, Ellis JD, Shen Z, Song DY, Pan Q, Watt AT, et al. The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol Cell. 2010;39(6):925-38.
21. Tripathi V, Shen Z, Chakraborty A, Giri S, Freier SM, Wu X, et al. Long noncoding RNA MALAT1 controls cell cycle progression by regulating the expression of oncogenic transcription factor B-MYB. PLoS Genet. 2013;9(3), e1003368.
22. Rajaram V, Knezevich S, Bove KE, Perry A, Pfeifer JD. DNA sequence of the translocation breakpoints in undifferentiated embryonal sarcoma arising in mesenchymal hamartoma of the liver harboring the t (11; 19)(q11; q13.4) translocation. Genes Chromosomes Cancer. 2007;46(5):508-13.
23. Davis IJ, Hsi BL, Arroyo JD, Vargas SO, Yeh YA, Motyckova G, et al. Cloning of an Alpha-TFEB fusion in renal tumors harboring the t (6; 11)(p21; q13) chromosome translocation. Proc Natl Acad Sci U S A. 2003;100(10):6051-6.
24. Wagner LA, Christensen CJ, Dunn DM, Spangrude GJ, Georgelas A, Kelley L, et al. EGO, a novel, noncoding RNA gene, regulates eosinophil granule protein transcript expression. Blood. 2007;109(12):5191-8.
25. Zhang X, Lian Z, Padden C, Gerstein MB, Rozowsky J, Snyder M, et al. A myelopoiesis-associated regulatory intergenic noncoding RNA transcript within the human HOXA cluster. Blood. 2009;113(11)):2526-34.
26. Zhang X, Weissman SM, Newburger PE. Long intergenic non-coding RNA HOTAIRM1 regulates cell cycle progression during myeloid maturation in NB4 human promyelocytic leukemia cells. RNA Biol. 2014;11(6):777-87.
27. Ma XY, Ma XC, Cai Q, Tang X. Long Non-Coding RNA Malat1 Regulates Gene Expression and Protein Function via Multiple-Layer and Flexible Manners. Austin J Pathology Lab Med. 2014;1(3):1-5.
28. Liu Y, Luo D, et al. Inheritable and Precise Large Genomic Deletions of Non-Coding RNA Genes in Zebrafish Using TALENs. PLoS ONE. 2013;8(10), e76387.
29. Gupta D, Shah HP, Malu K, Berliner N, Gaines P. Differentiation and characterization of myeloid cells. Curr Protoc Immunol. 2014;104:Unit 22F 25.
30. Johnson KD, Hsu AP, Ryu MJ, Wang J, Gao X, Boyer ME, et al. Cis-element mutated in GATA2-dependent immunodeficiency governs hematopoiesis and vascular integrity. J Clin Invest. 2012;122(10):3692-704.
31. Drissen R, von Lindern M, Kolbus A, Driegen S, Steinlein P, Beug H, et al. The erythroid phenotype of EKLF-null mice: defects in hemoglobin metabolism and membrane stability. Mol Cell Biol. 2005;25(12):5205-14.
32. Frontelo P, Manwani D, Galdass M, Karsunky H, Lohmann F, Gallagher PG, et al. Novel role for EKLF in megakaryocyte lineage commitment. Blood. 2007;110(12):3871-80.
33. Soddu S, Blandino G, Scardigli R, Coen S, Marchetti A, Rizzo MG, et al. Interference with p53 protein inhibits hematopoietic and muscle differentiation. J Cell Biol. 1996;134(1):193-204.
34. Bocchia M, Xu Q, Wesley U, Xu Y, Korontsvit T, Loganzo F, et al. Modulation of p53, WAF1/p21 and BCL-2 expression during retinoic acid-induced differentiation of NB4 promyelocytic cells. Leuk Res. 1997;21(5):439-47.
35. Halevy O. p53 gene is up-regulated during skeletal muscle cell differentiation. Biochem Biophys Res Commun. 1993;192(2):714-9.
36. Chen K, Perez-Stable C, D'Ippolito G, Schiller PC, Roos BA, Howard GA. Human bone marrow-derived stem cell proliferation is inhibited by hepatocyte growth factor via increasing the cell cycle inhibitors p53, p21 and p27. Bone. 2011;49(6):1194-204.
37. Mazzaro G, Bossi G, Coen S, Sacchi A, Soddu S. The role of wild-type p53 in the differentiation of primary hemopoietic and muscle cells. Oncogene. 1999;18(42):5831-5.
38. Jeffers LK, Duan K, Ellies LG, Seaman WT, Burger-Calderon RA, Diatchenko LB, et al. Correlation of transcription of MALAT-1, a novel noncoding RNA, with deregulated expression of tumor suppressor p53 in small DNA tumor virus models. J Cancer Ther. 2013;4(3).
39. Watts R, Ghozlan M, Hughey CC, Johnsen VL, Shearer J, Hittel DS. Myostatin inhibits proliferation and insulin-stimulated glucose uptake in mouse liver cells. Biochemistry and Cell Biology-Biochimie et Biologie Cellulaire. 2014;92(3):226-34.
40. Michalik KM, You X, Manavski Y, Doddaballapur A, Zörnig M, Braun T, et al. Long noncoding RNA MALAT1 regulates endothelial cell function and vessel growth. Circ Res. 2014;114(9):1389-97.